封面
市场调查报告书
商品编码
1678779

全球心电图贴片与动态心电图监测仪市场 - 2025 年至 2033 年

Global ECG Patches and Holter Monitor Market - 2025-2033

出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球心电图贴片和动态心电图监测市场规模达到 18.6454 亿美元,预计到 2033 年将达到 59.5062 亿美元,在 2025-2033 年预测期内的复合年增长率为 13.7%。

ECG 贴片和 Holter 监测仪是可穿戴医疗设备,用于持续心臟监测以检测心律不整。 ECG 贴片可以记录 24 至 72 小时内的心臟活动,而 Holter 监视器则是专为长期监护而设计的便携式、电池供电设备。这些设备可帮助医疗保健提供者分析心臟功能、诊断心血管状况并实现远端患者监控,从而改善心臟病的早期发现和管理。

市场动态:

驱动因素与约束因素

穿戴式和远端监控设备的采用日益增多

全球心电图贴片和动态心电图监测市场受到穿戴式和远端监测设备的兴起的推动,特别是由于心血管疾病的盛行率不断上升和数位健康技术的进步。穿戴式心电图贴片提供即时资料传输,使医疗保健提供者能够远端检测心臟异常。人工智慧和基于云端的分析的整合进一步增强了早期诊断和患者结果。市场扩张的动力来自于人们对家庭医疗保健的偏好,尤其是老年人和慢性病患者。

例如,2024 年 3 月,从三星分拆出来的数位医疗公司 Wellys 与 Artella Solutions 合作在美国推出了一项远距心臟监测服务。此次合作以 Welly 经 FDA 批准的 S-Patch 心电图监测解决方案为基础,目前采用经 FDA 批准的 S-Patch ExL 设备。 ExL 车型允许使用单一连结电池进行约 14 天的延长测试期,并于 2 月初获得了 FDA 批准。此次扩展使 Welly 能够扩大其在扩展 Holter 服务和移动心臟遥测服务中的覆盖范围。

高成本和报销挑战

预计心电图贴片和动态心电图监测仪的高成本也将在预测期内阻碍市场发展。这些产品的高成本可能会对医疗保健系统、医院和诊断诊所造成沉重的财务负担。预算限制可能会限制心电图贴片和动态心电图监测仪的广泛应用,尤其是在资源有限的环境中。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动态

  • 影响因素
    • 驱动程式
      • 穿戴式和远端监控设备的采用日益增多
    • 限制
      • 高成本和报销挑战
    • 机会
    • 影响分析

第五章:战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析:最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 6 章:按装置类型

  • 心电图贴片
  • 动态心电图监测

第 7 章:按应用

  • 监控
  • 诊断

第 8 章:按最终用户

  • 医院
  • 专科诊所
  • 门诊手术中心
  • 诊断中心
  • 其他的

第九章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章:竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 11 章:公司简介

  • Koninkluke Philips NV
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Bittium
  • Meditech Equipment Co., Ltd
  • ACS Diagnostics
  • Viatom Application Co., Ltd.
  • GE HealthCare Technologies Inc.
  • Hill-Rom Holdings, Inc.
  • Spacelabs Healthcare, Inc.
  • SmartCardia Inc.
  • dms-service LLC
  • Similar data will be provided for each market player.
  • ReelCardio 有限责任公司
    • 管道产品描述
    • 产品关键绩效指标 (KPI)
    • 主要活动
    • 市场进入时间表
    • 产品渗透率
    • 销售估计和预测
  • 巴迪诊断
  • 活体组织
  • 心臟洞察
  • 将为每个市场参与者提供类似的资料。

第 12 章:附录

简介目录
Product Code: MD7215

The Global ECG Patches and Holter Monitor Market reached US$ 1,864.54 million in 2024 and is expected to reach US$ 5,950.62 million by 2033, growing at a CAGR of 13.7% during the forecast period of 2025-2033.

ECG patches and Holter monitors are wearable medical devices used for continuous cardiac monitoring to detect irregular heart rhythms. ECG patches record heart activity over 24 to 72 hours, while Holter monitors are portable, battery-operated devices designed for long-term monitoring. These devices aid healthcare providers in analyzing heart function, diagnosing cardiovascular conditions, and enabling remote patient monitoring, improving early detection and management of heart diseases.

Market Dynamics: Drivers & Restraints

Increasing Adoption of Wearable and Remote Monitoring Devices

The global ECG patches and Holter monitor market is driven by the rise in wearable and remote monitoring devices, particularly due to the increasing prevalence of cardiovascular diseases and digital health technology advancements. Wearable ECG patches provide real-time data transmission, enabling healthcare providers to detect cardiac abnormalities remotely. The integration of AI and cloud-based analytics further enhances early diagnosis and patient outcomes. The market's expansion is driven by the preference for home-based healthcare, especially among the elderly and those with chronic conditions.

For instance, in March 2024, Wellysis, a digital healthcare company spun off from Samsung, launched a remote cardiac monitoring service in the US in partnership with Artella Solutions. The partnership builds on Wellysis' FDA-cleared S-Patch electrocardiogram monitoring solution, now featuring the FDA-cleared S-Patch ExL device. The ExL model allows for extended testing periods of about 14 days on a single coin battery and received FDA clearance in early February. This expansion enables Wellysis to expand its reach in the Extended Holter service and Mobile Cardiac Telemetry service.

High Cost and Reimbursement Challenges

The high costs associated with the ECG patches and Holter monitors is also expected to hamper the market over the forecast period. High costs associated with these products may impose a significant financial burden on healthcare systems, hospitals and diagnostic clinics. Budget constraints could limit the widespread adoption of ECG patches and Holter monitors, especially in resource-limited settings.

Segment Analysis

The global ECG patches and holter monitor market is segmented based on device type, application, end user and region.

Device Type:

ECG Patches in the device type segment are expected to dominate with the highest market share

ECG patches are a user-friendly, wireless, and comfortable alternative to traditional Holter monitors in cardiac monitoring. They provide continuous heart rhythm tracking, enabling early detection of arrhythmias and other cardiovascular conditions. The increasing adoption of ECG patches is driven by AI-powered analytics, cloud-based data sharing, and improved battery life. Their integration into home healthcare and ambulatory care settings reduces hospital visits and improves patient compliance.

ECG patches store data that can be later analyzed by healthcare professionals. This data provides a comprehensive overview of the patient's heart activity, aiding in accurate diagnosis and personalized treatment plans. ECG patches are increasingly being used as an alternative to traditional Holter monitors, offering a more discreet and comfortable option for prolonged heart monitoring. Patients can continue their daily activities without disruption while wearing these patches.

Geographical Analysis

North America is expected to hold a significant position in the ECG Patches and Holter Monitor market share.

North America is a major player in the global ECG patches and Holter monitor market due to the increasing prevalence of cardiovascular diseases, the geriatric population, and increased healthcare expenditure. The region's advanced healthcare infrastructure, favourable reimbursement policies, and technological advancements in wearable cardiac monitoring devices drive market growth. The presence of major market players and their innovative product launches and increased awareness about remote patient monitoring and early disease detection further enhance adoption rates.

Europe is growing at the fastest pace in the ECG Patches and Holter Monitor market.

Europe is driving the growth of the ECG patches and Holter monitor market due to healthcare digitization, government initiatives, and preventive healthcare. The aging population and improved healthcare access support the market's expansion. The adoption of wearable and AI-driven technologies, along with a well-established regulatory framework, further strengthens market penetration. Key medical technology companies and ongoing research into innovative diagnostic solutions further strengthen Europe's role in driving market growth.

For instance, in May 2024, Royal Philips successfully launched its ambulatory cardiac monitoring service in Spain using a wearable ePatch and the Cardiologs analytics platform. The service uses Holter monitors to detect life-threatening heart arrhythmias, improve patient comfort, and potentially improve clinical outcomes.

Competitive Landscape

The major global players in the ECG Patches and Holter Monitor market include Koninkluke Philips N.V, Bittium, Meditech Equipment Co., Ltd, ACS Diagnostics, Viatom Technology Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom Holdings, Inc., Spacelabs Healthcare, Inc, SmartCardia Inc, and dms-service LLC, among others.

Key Developments

  • In May 2024, Vivalink, a leading provider of digital healthcare solutions, launched a technology solution for Mobile Cardiac Telemetry (MCT) and Holter monitoring. The solution integrates remote patient monitoring technologies and advanced arrhythmia detection algorithms, streamlining deployment and enhancing patient care. This integration aims to reduce the cost of ambulatory cardiac monitoring services by streamlining delivery and enhancing patient care.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global ECG Patches and Holter Monitor market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Device Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Adoption of Wearable and Remote Monitoring Devices
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost and Reimbursement Challenges
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Forces Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Device Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 6.1.2. Market Attractiveness Index, By Device Type
  • 6.2. ECG Patches*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Holter Monitors

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Monitoring*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Diagnostics

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Diagnostic Centers
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Koninkluke Philips N.V.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Bittium
  • 11.3. Meditech Equipment Co., Ltd
  • 11.4. ACS Diagnostics
  • 11.5. Viatom Application Co., Ltd.
  • 11.6. GE HealthCare Technologies Inc.
  • 11.7. Hill-Rom Holdings, Inc.
  • 11.8. Spacelabs Healthcare, Inc.
  • 11.9. SmartCardia Inc.
  • 11.10. dms-service LLC
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. ReelCardio LLC*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Bardy Diagnostics
  • 11.13. AliveCor
  • 11.14. Cardiac Insight
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us